SoFi Technologies heads into July with the same two-sided tension that defined last week — elevated short interest, an options market flashing unusual caution — but the data has now hardened further rather than resolved.
The options signal remains the sharpest read on sentiment. The put/call ratio closed June at 0.50, nearly three standard deviations above its 20-day average of 0.43 — a z-score of 2.92 that has now held elevated for a full week rather than reverting as a one-day spike might. To put it plainly: demand for downside protection is running at its most persistent level of the past year, with the 52-week high on the PCR at 0.68 still providing overhead room, but the current reading is well outside normal. The last note flagged this spike as unusual; it has not faded.
Short interest tells a consistent story. Bears added roughly 14% to their aggregate position over the past month, pushing SI to just under 16% of the free float — 192 million shares short as of June 30. The weekly change is a more modest 2.3%, suggesting the pace of accumulation is slowing but not reversing. What matters here is the refusal to cover: SOFI gained 3.7% on the week and is up roughly 4% over the past month, yet shorts have not retreated. Borrow conditions offer no mechanical pressure to force them out either — cost to borrow eased 11% on the week to under 0.5%, the lowest level in months, and availability is running at roughly 117% of short interest, comfortably into normal territory. There is no squeeze dynamic in the lending market right now.
The Street skews cautious, and recent analyst moves reinforce that. Following the April earnings miss — SOFI fell 12.3% on the day and another 11.2% over the following week — the bulk of analyst action was target-price cuts while ratings held. Citigroup maintained Buy but cut its target to $30 from $37. Needham kept Buy but trimmed to $25. Goldman Sachs, UBS, and TD Cowen all cut targets while holding Neutral or Hold. The consensus mean target is $20.90 against a close of $17.93, implying roughly 17% upside, but the direction of analyst revision has been uniformly downward since the April print. The ORTEX short score of 66 ranks in the 7th percentile of the universe — meaning the stock screens as more heavily shorted than 93% of names tracked — while the EPS surprise factor at the 62nd percentile suggests the company has not been a consistent earnings disappointment, which gives the bulls something to point at ahead of July 27.
Insider activity in mid-June adds one genuinely interesting wrinkle. CEO Anthony Noto bought 13,888 shares at $18.06 on June 16 — a $251,000 open-market purchase — while the CTO and two EVPs were selling on the same day and the day after. The sells look like scheduled plan activity given the uniform pricing, but the CEO buy stands out as discretionary. Net insider activity over 90 days is a modest positive at roughly $10.6 million, driven largely by that single executive purchase against a backdrop of routine selling across the management team.
Peers have had a better week. UPST gained 12.6% and DAVE rose 17.2%, both far outpacing SOFI's 3.7% gain. That divergence in the fintech cohort is worth noting: the names without SOFI's short overhang and earnings risk moved more freely. What to watch from here is straightforward — with Q2 earnings on July 27, the question is whether short interest continues to build into the print, whether the CEO's open-market buy signals any confidence in the quarter, and whether the options market extends its defensive posture or begins to normalize as the date draws closer.
See the live data behind this article on ORTEX.
Open SOFI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
